Zobrazeno 1 - 10 of 3 865 pro vyhledávání: '"Verdura, E."'
1
Impianti di biogas di piccola taglia per la valorizzazione di scarti di frutta, verdura e di agrumi
Autor: Mapelli, Segato, Sala, Castelli
Publikováno v: Festival Futuro Ri-Generazioni, l'Era dell'Economia Circolare, altroconsumo, Un approccio sperimentale la seconda vita dei rifiuti, UniCredit Pavilion, Milano, 28-30 settembre 2018
info:cnr-pdr/source/autori:Mapelli, S., Segato, S., Sala, C., Castelli, S./congresso_nome:Festival Futuro Ri-Generazioni, l'Era dell'Economia Circolare, altroconsumo, Un approccio sperimentale la seconda vita dei rifiuti/congresso_luogo:UniCredit Pavilion, Milano/congresso_data:28-30 settembre 2018/anno:2018/pagina_da:/pagina_a:/intervallo_pagine
E' stato condotta un indagine sulla disponibilità di residui di prodotti agro-industriali (frutta, verdura, agrumi) presso un centinaio di Organizzazioni di Produttori ortofrutticoli (OP) distribuite in tutta Italia. Dalle analisi dei residui abbiam
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=cnr_________::a165749e9f59fe07c53fcf59ef1b9a88
http://www.cnr.it/prodotto/i/393836
Zobrazit plný text záznamu
2
Akademický článek
Altered tubulin detyrosination due to SVBP malfunction induces cytokinesis failure and senescence, underlying a complex hereditary spastic paraplegia.
Autor: Launay N; Neurometabolic Diseases Laboratory, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Hospital Duran i Reynals, Barcelona, Spain.; Center for Biomedical Research on Rare Diseases, (CIBERER U759) Ministry of Science Innovation and University, Madrid, Spain., Espinosa-Alcantud M; Chromatin Biology Laboratory, Josep Carreras Leukaemia Research Institute, Badalona, Spain., Verdura E; Neurometabolic Diseases Laboratory, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Hospital Duran i Reynals, Barcelona, Spain., Fernández-Eulate G; Nord-Est/Ile-de-France Neuromuscular Reference Center, Institute of Myology, Pitié-Salpêtrière Hospital, Paris, France.; Department of Neurology, Hospital Universitario Donostia, OSAKIDETZA-Department of Neurosciences, University of the Basque Cpuntry, San Sebastian, Spain., Ondaro J; Department of Neurosciences, Instituto Biodonostia, San Sebastián, Spain.; Center of Biomedical Research in Neurodegenerative Diseases (CIBERNED), CIBER, Ministry of Science, Innovation and University, Madrid, Spain., Iruzubieta P; Department of Neurology, Hospital Universitario Donostia, OSAKIDETZA-Department of Neurosciences, University of the Basque Cpuntry, San Sebastian, Spain.; Department of Neurosciences, Instituto Biodonostia, San Sebastián, Spain.; Center of Biomedical Research in Neurodegenerative Diseases (CIBERNED), CIBER, Ministry of Science, Innovation and University, Madrid, Spain.; Department of Medicine, School of Medicine, University of Deusto, Bilbao, Spain., Marsal M; ICFO-Institut de Ciencies Fotoniques, The Barcelona Institute of Science and Technology, Castelldefels, Spain., Schlüter A; Neurometabolic Diseases Laboratory, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Hospital Duran i Reynals, Barcelona, Spain., Ruiz M; Neurometabolic Diseases Laboratory, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Hospital Duran i Reynals, Barcelona, Spain.; Center for Biomedical Research on Rare Diseases, (CIBERER U759) Ministry of Science Innovation and University, Madrid, Spain., Fourcade S; Neurometabolic Diseases Laboratory, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Hospital Duran i Reynals, Barcelona, Spain.; Center for Biomedical Research on Rare Diseases, (CIBERER U759) Ministry of Science Innovation and University, Madrid, Spain., Rodríguez-Palmero A; Neurometabolic Diseases Laboratory, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Hospital Duran i Reynals, Barcelona, Spain.; Center for Biomedical Research on Rare Diseases, (CIBERER U759) Ministry of Science Innovation and University, Madrid, Spain.; Pediatric Neurology Unit, Department of Pediatrics, University Hospital Germans Trias i Pujol, Autonomous University of Barcelona, Badalona, Spain., Zulaica M; Department of Neurosciences, Instituto Biodonostia, San Sebastián, Spain., Sistiaga A; Center of Biomedical Research in Neurodegenerative Diseases (CIBERNED), CIBER, Ministry of Science, Innovation and University, Madrid, Spain.; Department of Personality, Assessment and Psychological Treatment Faculty of Psychology, University of the Basque Country (UPV/EHU), San Sebastian, Spain., Labayru G; Center of Biomedical Research in Neurodegenerative Diseases (CIBERNED), CIBER, Ministry of Science, Innovation and University, Madrid, Spain.; Department of Personality, Assessment and Psychological Treatment Faculty of Psychology, University of the Basque Country (UPV/EHU), San Sebastian, Spain., Loza-Alvarez P; ICFO-Institut de Ciencies Fotoniques, The Barcelona Institute of Science and Technology, Castelldefels, Spain., Vaquero A; Chromatin Biology Laboratory, Josep Carreras Leukaemia Research Institute, Badalona, Spain., Lopez de Munain A; Department of Neurology, Hospital Universitario Donostia, OSAKIDETZA-Department of Neurosciences, University of the Basque Cpuntry, San Sebastian, Spain.; Department of Neurosciences, Instituto Biodonostia, San Sebastián, Spain.; Center of Biomedical Research in Neurodegenerative Diseases (CIBERNED), CIBER, Ministry of Science, Innovation and University, Madrid, Spain.; Department of Medicine, School of Medicine, University of Deusto, Bilbao, Spain., Pujol A; Neurometabolic Diseases Laboratory, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Hospital Duran i Reynals, Barcelona, Spain.; Center for Biomedical Research on Rare Diseases, (CIBERER U759) Ministry of Science Innovation and University, Madrid, Spain.; Catalan Institution of Research and Advanced Studies (ICREA), Barcelona, Spain.
Publikováno v: Aging cell [Aging Cell] 2024 Oct 16, pp. e14355. Date of Electronic Publication: 2024 Oct 16.
Zobrazit plný text záznamu
5
Akademický článek
Clinical and Molecular Profiling in GNAO1 Permits Phenotype-Genotype Correlation.
Autor: Lasa-Aranzasti A; Department of Clinical and Molecular Genetics, Vall d'Hebron University Hospital, Barcelona, Spain.; Pediatric Neurology Research Group, Vall d'Hebron Research Institute (VHIR), Autonomous University of Barcelona, Barcelona, Spain.; Medicine Genetics Group, Vall d'Hebron Research Institute (VHIR), Autonomous University of Barcelona, Barcelona, Spain.; Department of Pediatrics, Faculty of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.; European Reference Network on Rare Congenital Malformations and Rare Intellectual Disability ERN-ITHACA, Paris, France., Larasati YA; Translational Research Centre in Oncohaematology, Department of Cell Physiology and Metabolism, Faculty of Medicine, University of Geneva, Geneva, Switzerland., da Silva Cardoso J; Pediatric Neurology Research Group, Vall d'Hebron Research Institute (VHIR), Autonomous University of Barcelona, Barcelona, Spain.; Serviço de Pediatria do Centro Materno infantil do Norte, Centro Hospitalar Universitário de Santo António, Porto, Portugal., Solis GP; Translational Research Centre in Oncohaematology, Department of Cell Physiology and Metabolism, Faculty of Medicine, University of Geneva, Geneva, Switzerland., Koval A; Translational Research Centre in Oncohaematology, Department of Cell Physiology and Metabolism, Faculty of Medicine, University of Geneva, Geneva, Switzerland., Cazurro-Gutiérrez A; Pediatric Neurology Research Group, Vall d'Hebron Research Institute (VHIR), Autonomous University of Barcelona, Barcelona, Spain.; Department of Pediatrics, Faculty of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain., Ortigoza-Escobar JD; Movement Disorders Unit, Department of Child Neurology, Institut de Recerca Sant Joan de Déu, Barcelona, Spain.; U-703 Center for Biomedical Research on Rare Diseases (CIBER-ER), Instituto de Salud Carlos III, Barcelona, Spain.; European Reference Network-Rare Neurological Diseases (ERN-RND), Barcelona, Spain., Miranda MC; European Reference Network-Rare Neurological Diseases (ERN-RND), Barcelona, Spain.; Department of Pediatrics Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain., De la Casa-Fages B; European Reference Network-Rare Neurological Diseases (ERN-RND), Barcelona, Spain.; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.; Movement Disorders Unit, Neurology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain., Moreno-Galdó A; Department of Pediatrics, Universitat Autónoma de Barcelona, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; CIBER of Rare diseases (CIBERER), Instituto de Salud Carlos III (ISCIII), Madrid, Spain., Tizzano EF; Department of Clinical and Molecular Genetics, Vall d'Hebron University Hospital, Barcelona, Spain.; Medicine Genetics Group, Vall d'Hebron Research Institute (VHIR), Autonomous University of Barcelona, Barcelona, Spain.; European Reference Network on Rare Congenital Malformations and Rare Intellectual Disability ERN-ITHACA, Paris, France., Gómez-Andrés D; Pediatric Neurology Research Group, Vall d'Hebron Research Institute (VHIR), Autonomous University of Barcelona, Barcelona, Spain.; European Reference Network-Rare Neurological Diseases (ERN-RND), Barcelona, Spain.; Department of Neurology, Vall Hebron University Hospital Barcelona, Barcelona, Spain., Verdura E; Pediatric Neurology Research Group, Vall d'Hebron Research Institute (VHIR), Autonomous University of Barcelona, Barcelona, Spain., Katanaev VL; Translational Research Centre in Oncohaematology, Department of Cell Physiology and Metabolism, Faculty of Medicine, University of Geneva, Geneva, Switzerland.; School of Medicine and Life Sciences, Far Eastern Federal University, Vladivostok, Russia., Pérez-Dueñas B; Pediatric Neurology Research Group, Vall d'Hebron Research Institute (VHIR), Autonomous University of Barcelona, Barcelona, Spain.; Department of Pediatrics, Faculty of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.; European Reference Network-Rare Neurological Diseases (ERN-RND), Barcelona, Spain.; Department of Pediatrics, Universitat Autónoma de Barcelona, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; CIBER of Rare diseases (CIBERER), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Publikováno v: Movement disorders : official journal of the Movement Disorder Society [Mov Disord] 2024 Sep; Vol. 39 (9), pp. 1578-1591. Date of Electronic Publication: 2024 Jun 16.
Zobrazit plný text záznamu
6
Report
Further Evidence of Cerebellar Cognitive Affective/Schmahmann Syndrome in RFC1-Related Syndrome.
Autor: Albajar I; Department of Neurology, Osakidetza-Basque Health Service, Hospital Universitario Donostia, Donostia-San Sebastian, Spain., Iruzubieta P; Department of Neurology, Osakidetza-Basque Health Service, Hospital Universitario Donostia, Donostia-San Sebastian, Spain.; Neurosciences, Biogipuzkoa Health Research Institute, Donostia-San Sebastian, Spain.; CIBERNED (CIBER, Institute Carlos III), Madrid, Spain.; Faculty of Medicine, University of Deusto, Bilbao, Spain., Barandiaran M; CIBERNED (CIBER, Institute Carlos III), Madrid, Spain.; Department of Neurology, Neuropsychology, Osakidetza-Basque Health Service, Hospital Universitario Donostia, Donostia-San Sebastian, Spain., Alves P; Department of Neurology, Neuropsychology, Osakidetza-Basque Health Service, Hospital Universitario Donostia, Donostia-San Sebastian, Spain.; Neurodegenerative Diseases Group, Biogipuzkoa Health Research Institute, Donostia-San Sebastian, Spain., Pujol A; Neurometabolic Disease Lab, Hospital Duran i Reynals, IDIBELL Gran Via 199, 08908 L'Hospitalet de Llobregat, Institut d'Investigacio Biomedica de Bellvitge, Barcelona, Spain.; CIBERER (CIBER, Institute Carlos III), Madrid, Spain., Verdura E; Neurometabolic Disease Lab, Hospital Duran i Reynals, IDIBELL Gran Via 199, 08908 L'Hospitalet de Llobregat, Institut d'Investigacio Biomedica de Bellvitge, Barcelona, Spain.; CIBERER (CIBER, Institute Carlos III), Madrid, Spain., Equiza J; Department of Neurology, Osakidetza-Basque Health Service, Hospital Universitario Donostia, Donostia-San Sebastian, Spain.; Neurological Intensive Care Unit, Montreal Neurological Institute-Hospital, McGill University, Montreal, Quebec, Canada., Urreta I; Clinical Epidemiology Unit, Osakidetza-Basque Health Service, Hospital Universitario Donostia, Donostia-San Sebastian, Spain.; Clinical Epidemiology, Biogipuzkoa Health Research Institute, Donostia-San Sebastian, Spain., Ruiz-Martínez J; Department of Neurology, Osakidetza-Basque Health Service, Hospital Universitario Donostia, Donostia-San Sebastian, Spain.; Neurosciences, Biogipuzkoa Health Research Institute, Donostia-San Sebastian, Spain.; CIBERNED (CIBER, Institute Carlos III), Madrid, Spain., Maneiro M; Department of Neurology, Osakidetza-Basque Health Service, Hospital Universitario Donostia, Donostia-San Sebastian, Spain., Fernandez-Torron R; Department of Neurology, Osakidetza-Basque Health Service, Hospital Universitario Donostia, Donostia-San Sebastian, Spain.; CIBERNED (CIBER, Institute Carlos III), Madrid, Spain.; Faculty of Medicine, University of Deusto, Bilbao, Spain., Poza JJ; Department of Neurology, Osakidetza-Basque Health Service, Hospital Universitario Donostia, Donostia-San Sebastian, Spain.; CIBERNED (CIBER, Institute Carlos III), Madrid, Spain.; Faculty of Medicine, University of Deusto, Bilbao, Spain., Mondragón E; Department of Neurology, Osakidetza-Basque Health Service, Hospital Universitario Donostia, Donostia-San Sebastian, Spain., de Munain AL; Department of Neurology, Osakidetza-Basque Health Service, Hospital Universitario Donostia, Donostia-San Sebastian, Spain.; CIBERNED (CIBER, Institute Carlos III), Madrid, Spain.; Faculty of Medicine, University of Deusto, Bilbao, Spain.; Neurosciences, Biodonostia Health Research Institute, Donostia-San Sebastian, Spain.
Publikováno v: Movement disorders : official journal of the Movement Disorder Society [Mov Disord] 2024 Jul; Vol. 39 (7), pp. 1246-1248.
Zobrazit plný text záznamu
7
Diagnosis of Genetic White Matter Disorders by Singleton Whole-Exome and Genome Sequencing Using Interactome-Driven Prioritization
Autor: Schluter, A, Rodriguez-Palmero, A, Verdura, E, Velez-Santamaria, V, Ruiz, M, Fourcade, S, Planas-Serra, L, Martinez, JJ, Guilera, C, Giros, M, Artuch, R, Yoldi, ME, O'Callaghan, M, Garcia-Cazorla, A, Armstrong, J, Marti, I, Rezola, EM, Redin, C, Mandel, JL, Conejo, D, Sierra-Corcoles, C, Beltran, S, Gut, M, Vazquez, E, Del Toro, M, Troncoso, M, Perez-Jurado, LA, Gutierrez-Solana, LG, de Munain, AL, Casasnovas, C, Aguilera-Albesa, S, Macaya, A, Pujol, A
Publikováno v: Neurology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Background and Objectives Genetic white matter disorders (GWMD) are of heterogeneous origin, with >100 causal genes identified to date. Classic targeted approaches achieve a molecular diagnosis in only half of all patients. We aimed to determine the
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::a37761368e2873ca437fb7a0c71ae40e
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=7321
Zobrazit plný text záznamu
10
Akademický článek
End-Truncated LAMB1 Causes a Hippocampal Memory Defect and a Leukoencephalopathy.
Autor: Aloui C; Université de Paris, INSERM UMR 1141 NeuroDiderot, Paris, France., Hervé D; Université de Paris, INSERM UMR 1141 NeuroDiderot, Paris, France.; AP-HP, Groupe Hospitalier Saint-Louis Lariboisière-Fernand-Widal, Service de Neurologie, Centre de Référence des Maladies Vasculaires Rares du Cerveau et de l'Œil (CERVCO), Paris, France., Marenne G; Université de Brest, Inserm, EFS, CHU Brest, UMR 1078, GGB, Brest, France., Savenier F; Université de Paris, INSERM UMR 1141 NeuroDiderot, Paris, France., Le Guennec K; Université de Paris, INSERM UMR 1141 NeuroDiderot, Paris, France., Bergametti F; Université de Paris, INSERM UMR 1141 NeuroDiderot, Paris, France., Verdura E; Université de Paris, INSERM UMR 1141 NeuroDiderot, Paris, France., Ludwig TE; Université de Brest, Inserm, EFS, CHU Brest, UMR 1078, GGB, Brest, France., Lebenberg J; Université de Paris, INSERM UMR 1141 NeuroDiderot, Paris, France., Jabeur W; Université de Paris, INSERM UMR 1141 NeuroDiderot, Paris, France., Morel H; Université de Paris, INSERM UMR 1141 NeuroDiderot, Paris, France.; AP-HP, Service de Génétique Moléculaire Neurovasculaire, Hôpital Saint-Louis, Paris, France., Coste T; Université de Paris, INSERM UMR 1141 NeuroDiderot, Paris, France.; AP-HP, Service de Génétique Moléculaire Neurovasculaire, Hôpital Saint-Louis, Paris, France., Demarquay G; Hôpital Neurologique, Hospices Civils de Lyon, Lyon Neuroscience Research Center (CRNL), Brain Dynamics and Cognition Team (Dycog), INSERM U1028, CNRS UMR5292, Lyon, France., Bachoumas P; Centre Hospitalier Public Du Cotentin, Cherbourg-en-Cotentin, France., Cogez J; CHU Caen, Department of Neurology, CHU de Caen Côte de Nacre, Caen, France., Mathey G; Neurology Unit, University Hospital of Nancy, Nancy, France., Bernard E; Department of Neurology, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Bron, France.; Institut NeuroMyoGène, INSERM-CNRS-UMR, Université Claude Bernard, Lyon, France., Chabriat H; Université de Paris, INSERM UMR 1141 NeuroDiderot, Paris, France.; AP-HP, Groupe Hospitalier Saint-Louis Lariboisière-Fernand-Widal, Service de Neurologie, Centre de Référence des Maladies Vasculaires Rares du Cerveau et de l'Œil (CERVCO), Paris, France., Génin E; Université de Brest, Inserm, EFS, CHU Brest, UMR 1078, GGB, Brest, France., Tournier-Lasserve E; Université de Paris, INSERM UMR 1141 NeuroDiderot, Paris, France.; AP-HP, Service de Génétique Moléculaire Neurovasculaire, Hôpital Saint-Louis, Paris, France.
Publikováno v: Annals of neurology [Ann Neurol] 2021 Dec; Vol. 90 (6), pp. 962-975. Date of Electronic Publication: 2021 Oct 20.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje